Barclays PLC purchased a new position in TruBridge, Inc. (NASDAQ:TBRG - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 12,559 shares of the company's stock, valued at approximately $150,000. Barclays PLC owned 0.08% of TruBridge as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of TruBridge during the 2nd quarter worth approximately $297,000. Cubist Systematic Strategies LLC acquired a new position in shares of TruBridge during the second quarter worth $740,000. Point72 DIFC Ltd purchased a new stake in shares of TruBridge during the 2nd quarter valued at $56,000. GAMMA Investing LLC purchased a new position in TruBridge during the 3rd quarter worth $26,000. Finally, Williams & Novak LLC purchased a new position in TruBridge during the 3rd quarter worth $234,000. 88.64% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on TBRG shares. Barclays lifted their target price on shares of TruBridge from $10.00 to $14.00 and gave the stock an "equal weight" rating in a research note on Monday, November 11th. Stephens lifted their price objective on shares of TruBridge from $13.00 to $17.00 and gave the stock an "equal weight" rating in a research note on Wednesday, November 20th. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $13.00 target price on shares of TruBridge in a research report on Friday, October 4th.
Read Our Latest Report on TruBridge
Insider Activity at TruBridge
In other TruBridge news, Director Mark V. Anquillare bought 2,500 shares of the stock in a transaction on Monday, November 25th. The shares were bought at an average price of $16.81 per share, with a total value of $42,025.00. Following the purchase, the director now directly owns 17,178 shares in the company, valued at $288,762.18. This trade represents a 17.03 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 3.60% of the stock is owned by corporate insiders.
TruBridge Stock Performance
NASDAQ TBRG traded up $0.08 on Thursday, hitting $23.00. 70,880 shares of the company's stock traded hands, compared to its average volume of 112,387. The firm's 50-day moving average price is $19.07 and its two-hundred day moving average price is $14.57. The firm has a market capitalization of $343.32 million, a PE ratio of -5.63, a P/E/G ratio of 4.49 and a beta of 0.67. The company has a current ratio of 1.80, a quick ratio of 1.78 and a debt-to-equity ratio of 1.00. TruBridge, Inc. has a 1-year low of $7.55 and a 1-year high of $23.64.
TruBridge (NASDAQ:TBRG - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by ($0.73). TruBridge had a negative net margin of 17.72% and a positive return on equity of 1.78%. The company had revenue of $83.83 million during the quarter, compared to analyst estimates of $82.30 million. During the same period last year, the firm earned $0.39 EPS. As a group, analysts expect that TruBridge, Inc. will post 0.07 EPS for the current year.
About TruBridge
(
Free Report)
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
Read More
Before you consider TruBridge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TruBridge wasn't on the list.
While TruBridge currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
